MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Development of an Item Bank for Assessing Psychosis in Parkinson’s Disease: A Systematic Review

    G. Mangone, M. Tosin, C. Goetz, G. Stebbins, T. Mestre (Chicago, USA)

    Objective: This study aimed to develop an item bank for assessing psychosis in Parkinson's disease (PD). Background: Psychosis is a common and debilitating symptom in…
  • 2023 International Congress

    Clinico-pathological correlations in atypical parkinsonism

    R. Fumi, M. Theilmann Jensen, L. Wu, D. Vaughan, V. Chelban, Y. Goh, R. Real, A. Martinez Carrasco, E. Jabbari, A. Church, J. Coebergh, C. Kobylecki, U. Nath, M. Hu, A. Misbahuddin, J. Sharma, L. Massey, E. Capps, A. Robinson, F. Roncaroli, A. Lees, O. Ansorge, K. Allison, T. Warner, J. Rohrer, T. Revesz, Z. Jaunmuktane, J. Rowe, H. Houlden, H. Morris (London, United Kingdom)

    Objective: We aim to assess diagnostic accuracy of the Parkinson-plus syndromes (PPS) using the current consensus criteria, whilst identifying the diagnostically most salient clinical features.…
  • 2023 International Congress

    Safety assessment of pimavanserin in Parkinson’s disease psychosis patients: Evidence from a systematic review and meta-analysis of randomized controlled trials

    G. Bano, A. Sharma (New Delhi, India)

    Objective: This systematic review and meta-analysis aimed to assess the safety profile of pimavanserin in Parkinson’s disease psychosis (PDP) patients from the available randomized controlled…
  • 2023 International Congress

    Impaired structural connectivity in Parkinson’s disease with probable RBD

    J. Oltra, I. Roura, A. Campabadal, C. Uribe, J. Pardo, MJ. Martí, Y. Compta, F. Valldeoriola, N. Bargallo, A. Iranzo, C. Junque, B. Segura (Barcelona, Spain)

    Objective: To characterize structural connectivity through whole-brain network-based statistics and graph theory implementation in treated Parkinson’s disease (PD) patients with probable REM sleep behavior disorder…
  • 2023 International Congress

    Sex Is Not a Major Determinant of Pallidus Internus Deep Brain Stimulation Outcome in Dystonia

    R. Telese, L. Romito, N. Golfrè Andreasi, G. Zorzi, A. Elia, S. Rinaldo, G. Devigili, R. Cilia, G. Messina, V. Levi, A. Franzini, R. Eleopra (Milan, Italy)

    Objective: To investigate the role of sex as a biological variable in efficacy and safety of GPi DBS in adults with dystonia. Background: Sex- related…
  • 2023 International Congress

    Quantitative gait analysis to evaluate changes in gait pattern after Botulinum toxin A injection by hemiparesis

    M. Pinter, M. Petrovicsova, Y. Teuschl, A. Dachenhausen, K. Matz, C. Bancher (Krems, Austria)

    Objective: This retrospective study aimed to assess the effect of Botulinum toxin A (BoNT-A) injections in the lower limbs of hemiparetic patients on gait parameters,…
  • 2023 International Congress

    Effectiveness of use of Pictographs on Levodopa packaging to ensure awareness of Levodopa/Carbidopa spacing with meals in patients of Idiopathic Parkinson’s disease.

    M. Matta, N. Sawal (Chandigarh, India)

    Objective: Food interferes with gastrointestinal absorption of levodopa which requires spacing with meals. This study aimed to evaluate the effect pictographs on Levodopa packaging Fig 1 on increasing patient…
  • 2023 International Congress

    The hypometabolism in anterior cingulate gyrus and thalamus: potential biomarkers of disease progression in progressive supranuclear palsy

    B. Wang, H. Wang (Hangzhou, China)

    Objective: This study aimed to identify differences in FDG uptake and metabolic covariant network (independent component analysis) in progressive supranuclear palsy (PSP) in comparison with…
  • 2023 International Congress

    Randomized Controlled Trial comparing continuous intrajejunal levodopa infusion and deep brain stimulation for Parkinson’s disease. Cost-effectiveness and cost-utility outcomes of the INVEST study

    D. van Poppelen, M. van Barreveld, R. de Bie, P. Schuurman, F. van Delft, G. Geurtsen, R. de Haan, M. Dijkgraaf, J. Dijk (Amsterdam, Netherlands)

    Objective: To determine the costs of continuous intrajejunal levodopa infusion (CILI) and deep brain stimulation (DBS) for Parkinson’s disease (PD), and to study the cost-effectiveness…
  • 2023 International Congress

    Mitochondrial DNA copy number is associated with the severity of motor symptoms and dementia in Parkinson’s disease

    S. Jo, JH. Oh, S. Lee, J. Lee, CO. Sung, SJ. Chung (Seoul, Republic of Korea)

    Objective: We aimed to investigate the diagnostic and prognostic role of blood mitochondrial DNA copy number (mtDNA-CN) measured by whole genome sequencing (WGS) in relation…
  • « Previous Page
  • 1
  • …
  • 577
  • 578
  • 579
  • 580
  • 581
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley